GLX-351322

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameGLX-351322
Drug Alias NameGLX-351322
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADPH oxidase 4 modulators
TargetsNADPH oxidase 4
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlucox Biotech AB
China Registration ClassN/A

Develop Information

Active CompaniesGlucox Biotech AB
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A